Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Xeris Biopharma Holdings, Inc. has 11 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Xeris Biopharma Holdings, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Xeris Biopharma Holdings, Inc.. Customers appear here when Xeris Biopharma Holdings, Inc. names them, or when a company names Xeris Biopharma Holdings, Inc. as a supplier in its own annual report.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“We have entered into a non-exclusive supply agreement with Bachem.”
FILING10-K0001867096-26-000016cik 0001867096
“We have entered into a supply agreement with Lonza.”
FILING10-K0001867096-26-000016cik 0001867096
“We have entered into a non-exclusive supply agreement with Pyramid.”
FILING10-K0001867096-26-000016cik 0001867096
“We have entered into a supply agreement with Regis.”
FILING10-K0001867096-26-000016cik 0001867096
“We have entered into a supply agreement with SHL.”
FILING10-K0001867096-26-000016cik 0001867096
“Taro produces all of our requirements for Keveyis pursuant to a supply agreement.”
FILING10-K0001867096-26-000016cik 0001867096
“For Gvoke, we currently rely on a number of single-source suppliers, such as Bachem API, Pyramid for drug product, and SHL for auto-injector and final product assembly, and we have entered into several supply agreements including with Bachem, Pyramid and SHL.”
FILING10-K0001867096-26-000016cik 0001867096
“Similarly, for Recorlev, we rely on a number of single-source suppliers, such as Regis for API and Lonza for finished drug product.”
FILING10-K0001867096-26-000016cik 0001867096
“Similarly, for Recorlev, we rely on a number of single-source suppliers, such as Regis for API and Lonza for finished drug product.”
FILING10-K0001867096-26-000016cik 0001867096
“For Gvoke, we currently rely on a number of single-source suppliers, such as Bachem API, Pyramid for drug product, and SHL for auto-injector and final product assembly, and we have entered into several supply agreements including with Bachem, Pyramid and SHL.”
FILING10-K0001867096-26-000016cik 0001867096
“For Gvoke, we currently rely on a number of single-source suppliers, such as Bachem API, Pyramid for drug product, and SHL for auto-injector and final product assembly, and we have entered into several supply agreements including with Bachem, Pyramid and SHL.”
FILING10-K0001867096-26-000016cik 0001867096
Watchlist prices, news filtered to it, and its next report on your desk.
XERS (Xeris Biopharma Holdings, Inc.) has 11 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Prev close 7.48 · opened flat. High/low 7.50 at 11:30 am ET, 7.42 at 2:00 pm ET.
Xeris Biopharma Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations